Filing Details
- Accession Number:
- 0001214659-23-016913
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-27 16:05:10
- Reporting Period:
- 2023-12-22
- Accepted Time:
- 2023-12-27 16:05:10
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 905874 | G Kenneth Langone | 375 Park Avenue Ste 2205 New York NY 10152 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-12-22 | 500,000 | $5.75 | 2,321,306 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 30,000 | Indirect | By wife |
| Common Stock | 130,000 | Indirect | By Invemed Associates LLC |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this Form 4 shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
- The reporting person is the principal equity holder and Chairman and CEO of Invemed Associates LLC. Pursuant to Instruction (4)(b)(iv) of Form 4, the reporting person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by such entity. The reporting person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed his pecuniary interest therein and/or are not actually distributed to him.
Billionaire Hedge Funds
